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Supplementary Table 1 – Objectively measured activity and V02 max across the study 
6/12 month means are adjusted for their baseline scores. Within-group differences are paired t-tests from un-adjusted scores between two time points. Accelerometer 
counts were converted to MVPA using widely accepted thresholds as described in the manuscript text. Briefly, each 60-second epoch where counts exceeded 1951 was 
considered to be MVPA. VO2 Max was assessed by two methods (Astrand-Ryhming and YMCA/ACSM) during a single Intervention test undertaken on a calibrated cycle 
ergometer and the mean of the two used. n is the number of outcomes at each time point. 
 
 
 
Mean (SD)                                  Mean (SE) Mean Difference at 
Baseline (95% CI) 
Mean Difference at 6 
months (95% CI) 
Mean Difference at 12 
months (95% CI) Baseline 6 months 12 months 
Activity       
Total counts (n) (49) (33) (30)    
CONTROL 386 (154) 399 (36) 339 (36)    
INTERVENTION 357 (125) 398 (33) 400 (34)    
Within CONTROL     43 (-34 to 119) -19 (-98 to 61) 
Within 
INTERVENTION 
    41 (-29 to 111) 43 (-41 to 127) 
INTERVENTION vs 
CONTROL 
   -29 (-108 to 51) -2 (-102 to 99)  61 (-42 to 163) 
MVPA (min/week) (n)                        (49) (33) (30)    
CONTROL 277 (153) 279 (43) 235 (36)    
INTERVENTION 243 (141) 285 (40) 273 (34)    
Within CONTROL     28 (-49 to 106) -12 (-93 to 69) 
Within 
INTERVENTION 
    34 (-58 to 127) 18 (-69 to 106) 
INTERVENTION vs 
CONTROL 
   -35 (-118 to 49) 6 (-114 to 126) 38 (-65 to 140) 
VO2max (ml/kg/min) (n)                    (58) (39) (37)    
CONTROL 35.14 (9.58) 33.85 (0.99) 33.69 (1.62)    
INTERVENTION 32.17 (5.61) 34.29 (0.96) 35.41 (1.19)    
Within CONTROL     -0.83 (-2.98 to 1.31) -0.72 (-3.27 to 1.84) 
Within 
INTERVENTION 
    0.43 (-1.69 to 2.66) 1.12 (-1.21 to 3.45) 
INTERVENTION vs 
CONTROL 
   -2.97 (-7.12 to 1.18) 0.44 (-2.39 to 3.27) 1.72 (-1.67 to 5.2) 
 
 
 
